(Q34446862)

2 August 2017

Multicentre 12-week double-blind comparison of doxazosin, prazosin and placebo in patients with mild to moderate essential hypertension (English)

1 reference

multicenter clinical trial

2 August 2017

0 references

0 references

essential hypertension

1 reference

Torvik D

1

1 reference

PubMed ID

2939870

2 August 2017

Madsbu HP

series ordinal

2

1 reference

PubMed ID

2939870

2 August 2017

language of work or name

English

0 references

publication date

1 January 1986

1 reference

British Journal of Clinical Pharmacology

2 August 2017

1 reference

2 August 2017

21 Suppl 1

1 reference

2 August 2017

69S-75S

1 reference

Epidemiology of coronary heart disease: the Framingham study.

2 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1400760

Prazosin Update A Review of its Pharmacological Properties and Therapeutic Use in Hypertension and Congestive Heart Failure

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1400760

Effect of alpha- and beta-blocker therapy on blood lipids: European experience

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1400760

Doxazosin, an alpha 1-adrenoceptor antagonist: pharmacokinetics and concentration-effect relationships in man

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1400760

A pharmacodynamic and pharmacokinetic assessment of a new alpha- adrenoceptor antagonist, doxazosin (UK33274) in normotensive subjects

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1400760

6 July 2018

To be taken as directed

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1400760

The Tromsø heart-study. High-density lipoprotein and coronary heart-disease: a prospective case-control study

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1400760

High-density lipoprotein cholesterol and antihypertensive drugs: the Oslo study

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1400760

Double-blind comparison of the effects of long-term treatment with doxazosin or atenolol on serum lipoproteins

28 July 2018

1 reference

Crossref

https://api.crossref.org/works/10.1111%2FJ.1365-2125.1986.TB02856.X

Effects of alpha- and beta-blocker antihypertensive therapy on blood lipids: A multicenter trial

21 January 2018

1 reference

12 December 2020

Effect of propranolol and prazosin on blood lipids. The Oslo Study

1 reference

12 December 2020

The antihypertensive effect of prazosin on mild to moderate hypertension, changes in plasma volume, extracellular volume and glomerular filtration rate

1 reference

12 December 2020

Treatment of mild hypertension: a five year controlled drug trial. The Oslo study

1 reference

12 December 2020

High-density lipoproteins and the risk of atherosclerosis

1 reference

12 December 2020

[Diet therapy of essential hypertension]

1 reference

12 December 2020

Editorial: Single daily dose of antidepressants

1 reference

12 December 2020

10.1111/J.1365-2125.1986.TB02856.X

Identifiers

DOI

1 reference

2 August 2017

1 reference

2 August 2017

1 reference

PubMed ID

2939870